Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis

Rita Padoan, S. Genoni, E. Moretti, M. Seia, A. Giunta, C. Corbetta

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

A study was performed on the delayed diagnosis of cystic fibrosis (CF) in infants who had false-negative results in a neonatal screening programme. The genetic and clinical features of false-negative infants in this screening programme were assessed together with the efficiency of the screening procedure in the Lombardia region. In total, 774 687 newborns were screened using a two-step immunoreactive trypsinogen (IRT) (in the years 1990-1992), IRT/IRT + delF508 (1993-1998) or IRT/IRT + polymerase chain reaction (PCR) and oligonucleotide ligation assay (OLA) protocol (1998-1999). Out of 196 CF children born in the 10 y period 15 were false negative on screening (7.6%) and molecular analysis showed a high variability in the genotypes. The cystic fibrosis transmembrane regulator (CFTR) gene mutations identified were delF508, D1152H, R1066C, R334W, G542X, N1303K, F1052V, A2120T, 3849 + 10kbC → T, 2789 + 5G → A, 5T12TG and the novel mutation D110E. In three patients no mutation was identified after denaturing gradient gel electrophoresis of the majority of CFTR gene exons. Conclusion: The clinical phenotypes of CF children diagnosed by their symptoms at different ages were very mild. None of them presented with a severe lung disease. The majority of them did not seem to have been damaged by the delayed diagnosis. The combination of IRT assay plus genotype analysis (1998-1999) appears to be a more reliable method of detecting CF than IRT measurement alone or combined with only the delF508 mutation.

Original languageEnglish
Pages (from-to)82-87
Number of pages6
JournalActa Paediatrica, International Journal of Paediatrics
Volume91
Issue number1
DOIs
Publication statusPublished - 2002

Fingerprint

Trypsinogen
Neonatal Screening
Cystic Fibrosis
Mutation
Delayed Diagnosis
Regulator Genes
Genotype
Denaturing Gradient Gel Electrophoresis
Oligonucleotides
Lung Diseases
Ligation
Exons
Newborn Infant
Phenotype
Polymerase Chain Reaction

Keywords

  • CFTR
  • Cystic fibrosis
  • False negative
  • IRT
  • Neonatal screening

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis. / Padoan, Rita; Genoni, S.; Moretti, E.; Seia, M.; Giunta, A.; Corbetta, C.

In: Acta Paediatrica, International Journal of Paediatrics, Vol. 91, No. 1, 2002, p. 82-87.

Research output: Contribution to journalArticle

@article{eeece9f64a5d4154b8e458d8e7761df2,
title = "Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis",
abstract = "A study was performed on the delayed diagnosis of cystic fibrosis (CF) in infants who had false-negative results in a neonatal screening programme. The genetic and clinical features of false-negative infants in this screening programme were assessed together with the efficiency of the screening procedure in the Lombardia region. In total, 774 687 newborns were screened using a two-step immunoreactive trypsinogen (IRT) (in the years 1990-1992), IRT/IRT + delF508 (1993-1998) or IRT/IRT + polymerase chain reaction (PCR) and oligonucleotide ligation assay (OLA) protocol (1998-1999). Out of 196 CF children born in the 10 y period 15 were false negative on screening (7.6{\%}) and molecular analysis showed a high variability in the genotypes. The cystic fibrosis transmembrane regulator (CFTR) gene mutations identified were delF508, D1152H, R1066C, R334W, G542X, N1303K, F1052V, A2120T, 3849 + 10kbC → T, 2789 + 5G → A, 5T12TG and the novel mutation D110E. In three patients no mutation was identified after denaturing gradient gel electrophoresis of the majority of CFTR gene exons. Conclusion: The clinical phenotypes of CF children diagnosed by their symptoms at different ages were very mild. None of them presented with a severe lung disease. The majority of them did not seem to have been damaged by the delayed diagnosis. The combination of IRT assay plus genotype analysis (1998-1999) appears to be a more reliable method of detecting CF than IRT measurement alone or combined with only the delF508 mutation.",
keywords = "CFTR, Cystic fibrosis, False negative, IRT, Neonatal screening",
author = "Rita Padoan and S. Genoni and E. Moretti and M. Seia and A. Giunta and C. Corbetta",
year = "2002",
doi = "10.1080/080352502753458012",
language = "English",
volume = "91",
pages = "82--87",
journal = "Acta Paediatrica, International Journal of Paediatrics",
issn = "0803-5253",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Genetic and clinical features of false-negative infants in a neonatal screening programme for cystic fibrosis

AU - Padoan, Rita

AU - Genoni, S.

AU - Moretti, E.

AU - Seia, M.

AU - Giunta, A.

AU - Corbetta, C.

PY - 2002

Y1 - 2002

N2 - A study was performed on the delayed diagnosis of cystic fibrosis (CF) in infants who had false-negative results in a neonatal screening programme. The genetic and clinical features of false-negative infants in this screening programme were assessed together with the efficiency of the screening procedure in the Lombardia region. In total, 774 687 newborns were screened using a two-step immunoreactive trypsinogen (IRT) (in the years 1990-1992), IRT/IRT + delF508 (1993-1998) or IRT/IRT + polymerase chain reaction (PCR) and oligonucleotide ligation assay (OLA) protocol (1998-1999). Out of 196 CF children born in the 10 y period 15 were false negative on screening (7.6%) and molecular analysis showed a high variability in the genotypes. The cystic fibrosis transmembrane regulator (CFTR) gene mutations identified were delF508, D1152H, R1066C, R334W, G542X, N1303K, F1052V, A2120T, 3849 + 10kbC → T, 2789 + 5G → A, 5T12TG and the novel mutation D110E. In three patients no mutation was identified after denaturing gradient gel electrophoresis of the majority of CFTR gene exons. Conclusion: The clinical phenotypes of CF children diagnosed by their symptoms at different ages were very mild. None of them presented with a severe lung disease. The majority of them did not seem to have been damaged by the delayed diagnosis. The combination of IRT assay plus genotype analysis (1998-1999) appears to be a more reliable method of detecting CF than IRT measurement alone or combined with only the delF508 mutation.

AB - A study was performed on the delayed diagnosis of cystic fibrosis (CF) in infants who had false-negative results in a neonatal screening programme. The genetic and clinical features of false-negative infants in this screening programme were assessed together with the efficiency of the screening procedure in the Lombardia region. In total, 774 687 newborns were screened using a two-step immunoreactive trypsinogen (IRT) (in the years 1990-1992), IRT/IRT + delF508 (1993-1998) or IRT/IRT + polymerase chain reaction (PCR) and oligonucleotide ligation assay (OLA) protocol (1998-1999). Out of 196 CF children born in the 10 y period 15 were false negative on screening (7.6%) and molecular analysis showed a high variability in the genotypes. The cystic fibrosis transmembrane regulator (CFTR) gene mutations identified were delF508, D1152H, R1066C, R334W, G542X, N1303K, F1052V, A2120T, 3849 + 10kbC → T, 2789 + 5G → A, 5T12TG and the novel mutation D110E. In three patients no mutation was identified after denaturing gradient gel electrophoresis of the majority of CFTR gene exons. Conclusion: The clinical phenotypes of CF children diagnosed by their symptoms at different ages were very mild. None of them presented with a severe lung disease. The majority of them did not seem to have been damaged by the delayed diagnosis. The combination of IRT assay plus genotype analysis (1998-1999) appears to be a more reliable method of detecting CF than IRT measurement alone or combined with only the delF508 mutation.

KW - CFTR

KW - Cystic fibrosis

KW - False negative

KW - IRT

KW - Neonatal screening

UR - http://www.scopus.com/inward/record.url?scp=0036180809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036180809&partnerID=8YFLogxK

U2 - 10.1080/080352502753458012

DO - 10.1080/080352502753458012

M3 - Article

C2 - 11883825

AN - SCOPUS:0036180809

VL - 91

SP - 82

EP - 87

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 1

ER -